Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5936171, 13 pages
https://doi.org/10.1155/2017/5936171
Research Article

Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis

1Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
2Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
3Shanghai Key Laboratory of Children’s Digestion and Nutrition, Shanghai 200092, China

Correspondence should be addressed to Qin Pan; ten.haey@niq_nap and Jian-Gao Fan; moc.621@4002revilyttaf

Received 8 January 2017; Accepted 7 March 2017; Published 21 June 2017

Academic Editor: Elena Grasselli

Copyright © 2017 Xing-Ya Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P.-L. Liew, W.-J. Lee, Y.-C. Lee, H.-H. Wang, W. Wang, and Y.-C. Lin, “Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease,” Obesity Surgery, vol. 16, no. 12, pp. 1584–1593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Richard and I. Lingvay, “Hepatic steatosis and type 2 diabetes: current and future treatment considerations,” Expert Review of Cardiovascular Therapy, vol. 9, no. 3, pp. 321–328, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Gaggini, M. Morelli, E. Buzzigoli, R. A. DeFronzo, E. Bugianesi, and A. Gastaldelli, “Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease,” Nutrients, vol. 5, no. 5, pp. 1544–1560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. C. Bertot and L. A. Adams, “The natural course of non-alcoholic fatty liver disease,” International Journal of Molecular Sciences, vol. 17, no. 5, article 774, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Federico, M. Dallio, M. Masarone et al., “The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction,” European Review for Medical and Pharmacological Sciences, vol. 20, no. 22, pp. 4731–4741, 2016. View at Google Scholar
  6. H. Moshayedi, R. Ahrabi, A. Mardani et al., “Association between non-alcoholic fatty liver disease and ischemic stroke,” Iranian Journal of Neurology, vol. 13, no. 3, pp. 144–148, 2014. View at Google Scholar
  7. I. Mikolasevic, L. Orlic, D. Stimac et al., “Non-alcoholic fatty liver disease and colorectal cancer,” Postgraduate Medical Journal, vol. 93, no. 1097, pp. 153–158, 2017. View at Google Scholar
  8. C. D. Williams, J. Stengel, M. I. Asike et al., “Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study,” Gastroenterology, vol. 140, no. 1, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Caballería, G. Pera, M. A. Auladell et al., “Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 1, pp. 24–32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Fung, C. K. Lee, M. Chan et al., “High prevalence of non‐alcoholic fatty liver disease in the Chinese—results from the Hong Kong liver health census,” Liver International, vol. 35, no. 2, pp. 542–549, 2015. View at Google Scholar
  11. G. B. Goh, C. Kwan, S. Y. Lim et al., “Perceptions of non-alcoholic fatty liver disease—an Asian community-based study,” Gastroenterol Rep (Oxf), vol. 4, no. 2, pp. 131–135, 2016. View at Google Scholar
  12. T. B. Hansen, T. I. Jensen, B. H. Clausen et al., “Natural RNA circles function as efficient microRNA sponges,” Nature, vol. 495, no. 7441, pp. 384–388, 2013. View at Google Scholar
  13. S. Memczak, M. Jens, A. Elefsinioti et al., “Circular RNAs are a large class of animal RNAs with regulatory potency,” Nature, vol. 495, no. 7441, pp. 333–338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Zheng, C. Bao, W. Guo et al., “Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs,” Nature Communications, vol. 7, article 11215, 2016. View at Publisher · View at Google Scholar
  15. W. W. Du, W. Yang, E. Liu, Z. Yang, P. Dhaliwal, and B. B. Yang, “Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2,” Nucleic Acids Research, vol. 44, no. 6, pp. 2846–2858, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Xu, S. Guo, W. Li, and P. Yu, “The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells,” Scientific Reports, vol. 5, article 12453, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-P. Lin, S. Ye, Y. Long et al., “Circular RNA expression alterations are involved in OGD/R-induced neuron injury,” Biochemical and Biophysical Research Communications, vol. 471, no. 1, pp. 52–56, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Wang, B. Long, F. Liu et al., “A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223,” European Heart Journal, vol. 37, no. 33, pp. 2602–2611, 2016. View at Google Scholar
  19. E. Grasselli, A. Voci, L. Canesi et al., “3,5-Diiodo-L-thyronine modifies the lipid droplet composition in a model of hepatosteatosis,” Cellular Physiology and Biochemistry, vol. 33, no. 2, pp. 344–356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Wang, Y. Zhang, L. Huang et al., “Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 12, pp. 16020–16025, 2015. View at Google Scholar
  21. C. M. Tang, M. Zhang, L. Huang et al., “CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts,” Scientific Reports, vol. 7, article 40342, 2017. View at Google Scholar
  22. P. Li, S. Chen, H. Chen et al., “Using circular RNA as a novel type of biomarker in the screening of gastric cancer,” Clinica Chimica Acta, vol. 444, pp. 132–136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. J. G. A. Whitehill, S. O. Opiyo, J. L. Koch, D. A. Herms, D. F. Cipollini, and P. Bonello, “Interspecific comparison of constitutive ash phloem phenolic chemistry reveals compounds unique to manchurian ash, a species resistant to emerald ash borer,” Journal of Chemical Ecology, vol. 38, no. 5, pp. 499–511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Liu, J. Du, J. Liu, and B. Wen, “Identification of key target genes and pathways in laryngeal carcinoma,” Oncology Letters, vol. 12, no. 2, pp. 1279–1286, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Yan, F. Yuan, X. Chen, and C. Dong, “Bioinformatics analysis to identify the differentially expressed genes of glaucoma,” Molecular Medicine Reports, vol. 12, no. 4, pp. 4829–4836, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-G. Zhang, H.-L. Yang, Y. Long, and W.-L. Li, “Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia,” BJOG, vol. 123, no. 13, pp. 2113–2118, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Shang, G. Li, H. Liu et al., “Comprehensive circular RNA profiling reveals that hsa-circ-0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development,” Medicine, vol. 95, no. 22, article e3811, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Pan, Y. Guo, Y. Luo, H. Li, and Y. Xu, “MicroRNA expression profiling of Chinese follicular lymphoma by microarray: a preliminary study,” International Immunopharmacology, vol. 39, pp. 41–47, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Dennis Jr., B. T. Sherman, D. A. Hosack et al., “DAVID: database for annotation, visualization, and integrated discovery,” Genome Biol, vol. 4, no. 5, p. 3, 2003. View at Google Scholar
  30. D. Dupuy, N. Bertin, C. A. Hidalgo et al., “Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans,” Nature Biotechnology, vol. 25, no. 6, pp. 663–668, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Kanehisa, S. Goto, S. Kawashima et al., “The KEGG resource for deciphering the genome,” Nucleic Acids Research, vol. 32, supplement 1, pp. D277–D280, 2004. View at Google Scholar
  32. A. S. Marriott, O. Vasieva, and Y. Fang, “NUDT2 disruption elevates diadenosine tetraphosphate (Ap4A) and down-regulates immune response and cancer promotion genes,” PLoS One, vol. 11, no. 5, Article ID e0154674, 2016. View at Google Scholar
  33. J.-G. Joung, K.-B. Hwang, J.-W. Nam, S.-J. Kim, and B.-T. Zhang, “Discovery of microRNA-mRNA modules via population-based probabilistic learning,” Bioinformatics, vol. 23, no. 9, pp. 1141–1147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Shalgi, D. Lieber, M. Oren, and Y. Pilpel, “Global and local architecture of the mammalian microRNA-transcription factor regulatory network,” PLoS Computational Biology, vol. 3, no. 7, article e131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Zhang, D. Wu, M. Aldarouish et al., “ETS-1: a potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer,” International Journal of Oncology, vol. 50, no. 1, pp. 232–240, 2016. View at Google Scholar
  36. E. G. Cerami, B. E. Gross, E. Demir et al., “Pathway Commons, a web resource for biological pathway data,” Nucleic Acids Research, vol. 39, no. 1, pp. D685–D690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Cao, X. Zhao, S. Li et al., “Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2α,” Cellular Physiology and Biochemistry, vol. 34, no. 5, pp. 1427–1441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Yang, L. Sun, Z. Li, and P. Gao, “Noncoding RNAs in regulation of cancer metabolic reprogramming,” Advances in Experimental Medicine and Biology, vol. 927, pp. 191–215, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Donkor, M. Sariahmetoglu, J. Dewald, D. N. Brindley, and K. Reue, “Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns,” Journal of Biological Chemistry, vol. 282, no. 6, pp. 3450–3457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. B. N. Finck, M. C. Gropler, Z. Chen et al., “Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα regulatory pathway,” Cell Metabolism, vol. 4, no. 3, pp. 199–210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. C. T. Shearn, K. E. Mercer, D. J. Orlicky et al., “Short term feeding of a high fat diet exerts an additive effect on hepatocellular damage and steatosis in liver-specific PTEN knockout mice,” PLoS ONE, vol. 9, no. 5, Article ID e96553, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H. I. Lee and M. K. Lee, “Coordinated regulation of scopoletin at adipose tissue-liver axis improved alcohol-induced lipid dysmetabolism and inflammation in rats,” Toxicol Lett, vol. 237, no. 3, pp. 210–218, 2015. View at Google Scholar
  43. Q. Deng, X. Li, S. Fu et al., “SREBP-1c gene silencing can decrease lipid deposits in bovine hepatocytes cultured in vitro,” Cell Physiol Biochem, vol. 33, no. 5, pp. 1568–1578, 2014. View at Google Scholar
  44. J. J. Lehman, P. M. Barger, A. Kovacs, J. E. Saffitz, D. M. Medeiros, and D. P. Kelly, “Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis,” Journal of Clinical Investigation, vol. 106, no. 7, pp. 847–856, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. J. M. Huss, R. P. Kopp, and D. P. Kelly, “Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and –gamma: identification of novel Leucine-rich interaction motif within PGC-1alpha,” The Journal of Biological Chemistry, vol. 277, no. 43, pp. 40265–40274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. R. B. Vega, J. M. Huss, and D. P. Kelly, “The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes,” Molecular and Cellular Biology, vol. 20, no. 5, pp. 1868–1876, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Everitt, M. Hu, J. M. Ajmo et al., “Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 304, no. 1, pp. G38–G47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. T. R. Peterson, S. S. Sengupta, T. E. Harris et al., “MTOR complex 1 regulates lipin 1 localization to control the srebp pathway,” Cell, vol. 146, no. 3, pp. 408–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Hirotsu, N. Hataya, F. Katsuok, and M. Yamamoto, “NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the lipin1 and PGC-1β genes,” Molecular and Cellular Biology, vol. 32, no. 14, pp. 2760–2770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. Chen, M. C. Gropler, M. S. Mitra, and B. N. Finck, “Complex interplay between the lipin 1 and the hepatocyte nuclear factor 4 α (HNF4α) pathways to regulate liver lipid metabolism,” PLoS ONE, vol. 7, no. 12, Article ID e51320, 2012. View at Publisher · View at Google Scholar · View at Scopus